XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for... XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States. Show more
AUSTIN, Texas, June 18, 2024 (GLOBE NEWSWIRE) -- XBiotechΒ (NASDAQ: XBIT) announced today data from its Phase 1/Phase 2 randomized, double-blind, placebo-controlled multi-center study for...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.55 | -7.54458161866 | 7.29 | 7.98 | 6.51 | 95194 | 7.02146028 | CS |
4 | 0.2 | 3.05810397554 | 6.54 | 7.98 | 5.62 | 54164 | 6.76107454 | CS |
12 | 1.25 | 22.7686703097 | 5.49 | 7.98 | 5.0201 | 65584 | 6.52438152 | CS |
26 | -0.76 | -10.1333333333 | 7.5 | 9.96 | 4.24 | 101090 | 6.67971194 | CS |
52 | 2.38 | 54.5871559633 | 4.36 | 9.96 | 3.51 | 66159 | 6.37702825 | CS |
156 | -7.9 | -53.9617486339 | 14.64 | 16.47 | 3 | 65163 | 6.76679384 | CS |
260 | -3.6 | -34.8162475822 | 10.34 | 33.2 | 3 | 134554 | 14.3863366 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.